Clinical Trial Update: Antipsychotic Discontinuation in High-risk Subjects

View source ↗

Summary

A clinical trial evaluating antipsychotic discontinuation in high-risk individuals with schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | Status: WITHDRAWN